谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 373 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
AURKA Blockage As a Strategy to Overcome Resistance to Olaparib and Platinum in High-Grade Ovarian Cancer (HGOC)
Juan Jose Martinez-Pretel,Victoria Heredia, Miriam Ruiz Linuesa, Paloma Sanchez Serrano, Lidia Gonzalez Villena,Marta Mendiola,Andres Redondo,Begona Pineda,Jose Alejandro Perez-Fidalgo
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)
引用0浏览0引用
0
0
Niraparib First-Line Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian Cancer: Final Overall Survival Results from PRIMA/ENGOT-OV26/GOG-3012 Trial
B.J. Monk,M.P. Barretina-Ginesta, B. Pothuri, I. Vergote,W. Graybill, M.R. Mirza, C.C. McCormick, D. Lorusso, R.G. Moore, G. Freyer,R.E. O’Cearbhaill, F. Heitz,D.M. O’Malley,A. Redondo, M.S. Shahin,C. Vulsteke, W.H. Bradley,C.A. Haslund,D.M. Chase, C. Pisano
Annals of Oncology (2024)
引用0浏览0WOS引用
0
0
Periosteal Ewing Sarcoma with Distant Metastases: Report of Two Patients and Review of the Literature
Eva M. Pena-Burgos, Maria C. Diez-Corral,Eduardo J. Ortiz-Cruz,Daniel Bernabeu,Mar Tapia-Vine,Andres Redondo, Antonio Perez-Martinez, Alberto Pelaez, Clara Venegas Mascaro,Adela Escudero Lopez,Jose J. Pozo-Kreilinger
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2024)
引用0浏览0WOS引用
0
0
Atezolizumab Versus Placebo in Combination with Bevacizumab and Non-Platinum-based Chemotherapy in Recurrent Ovarian Cancer: Final Overall and Progression-Free Survival Results from the AGO-OVAR 2.29/Engot-Ov34 Study
Frederik Marme,Philipp Harter,Andres Redondo,Alexander Reuss, Isabelle Laure Ray-Coquard,Kristina Lindemann,Christian Kurzeder, Els Van Nieuwenhuysen, Charlotte Bellier,Klaus Pietzner, Ahmed El-Balat, Carmen Garcia-Duran,Pauline Wimberger, Jose Alejandro Perez-Fidalgo,Frederic Selle, Nikolaus de Gregorio,Alexander Burges, Ignacio Romero,Annette Hasenburg,Patricia Pautier
JOURNAL OF CLINICAL ONCOLOGYno. 17_SUPPL (2024): LBA5501-LBA5501
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 374

#Citation: 12805

H-Index: 38

G-Index: 112

Sociability: 8

Diversity: 0

Activity: 4

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn